HX BLDG MAT (06655) Income Statement & Earnings

16.240
+0.030+0.19%

Not Open May 6 16:07 CST

33.76BMarket Cap9.18P/E (TTM)

HX BLDG MAT (06655) Income Statement

All

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q9)Sep 30, 2025

(Q6)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

Turnover

24.40%8.91B

3.31%35.35B

1.27%25.03B

-1.17%16.05B

1.10%7.16B

1.36%34.22B

2.29%24.72B

2.56%16.24B

6.87%7.08B

10.79%33.76B

Operating income

24.40%8.91B

3.31%35.35B

1.27%25.03B

-1.17%16.05B

1.10%7.16B

1.36%34.22B

2.29%24.72B

2.56%16.24B

6.87%7.08B

10.79%33.76B

Operating expenses

-16.43%-6.16B

4.28%-24.67B

6.03%-17.65B

8.00%-11.41B

4.37%-5.29B

-4.16%-25.77B

-5.46%-18.78B

-3.56%-12.4B

-4.65%-5.53B

-10.05%-24.74B

Gross profit

46.96%2.75B

26.46%10.68B

24.35%7.38B

20.84%4.64B

20.62%1.87B

-6.31%8.45B

-6.59%5.94B

-0.51%3.84B

15.61%1.55B

12.86%9.02B

Selling expenses

-17.90%-447.49M

-14.37%-1.72B

0.68%-1.19B

3.21%-762.59M

4.29%-379.55M

1.26%-1.5B

-7.82%-1.2B

-13.90%-787.87M

-6.49%-396.56M

-10.72%-1.52B

Administrative expenses

-24.97%-573.41M

-18.28%-2.22B

-9.45%-1.49B

-3.50%-939.87M

0.24%-458.85M

-3.34%-1.88B

-5.16%-1.36B

-13.23%-908.11M

-15.87%-459.96M

-14.96%-1.82B

Research and development expenses

4.41%-30.42M

-3.13%-246.22M

7.90%-107.68M

-1.79%-72.22M

6.37%-31.82M

20.71%-238.74M

29.66%-116.92M

-21.62%-70.95M

-191.83%-33.98M

-285.22%-301.1M

Profit from asset sales

8,584.61%22.63M

-88.69%84.84M

-21.97%15.6M

-107.35%-453.06K

-139.26%-266.72K

75.80%749.84M

186.88%19.99M

16.07%6.16M

207.70%679.43K

6,055.61%426.53M

Revaluation surplus

74.34%-3.44M

-125.22%-2.79M

-118.60%-2.38M

-65.82%2.13M

-1,689.91%-13.4M

130.31%11.05M

134.61%12.82M

116.17%6.23M

102.10%842.79K

-291.91%-36.44M

-Changes in the fair value of other assets

74.34%-3.44M

-125.22%-2.79M

-118.60%-2.38M

-65.82%2.13M

-1,689.91%-13.4M

130.31%11.05M

134.61%12.82M

116.17%6.23M

102.10%842.79K

-291.91%-36.44M

Impairment and provision

-49.78%555.96K

36.82%-108.65M

3.35%-38.03M

21.13%-30.29M

-50.90%1.11M

16.46%-171.98M

25.34%-39.35M

35.28%-38.4M

123.12%2.26M

-52.05%-205.87M

-Other impairment is provision

-49.78%555.96K

36.82%-108.65M

3.35%-38.03M

21.13%-30.29M

-50.90%1.11M

16.46%-171.98M

25.34%-39.35M

35.28%-38.4M

123.12%2.26M

-52.05%-205.87M

Special items of operating profit

-15.26%25.62M

-28.04%217.68M

-7.92%135.34M

-16.96%72.29M

-20.91%30.24M

29.08%302.52M

-17.79%146.99M

-23.02%87.06M

-45.65%38.23M

-0.04%234.36M

Operating profit

86.08%1.55B

18.96%5.84B

43.51%4.05B

41.70%2.49B

54.76%832.06M

-2.77%4.91B

-16.35%2.82B

-12.28%1.76B

21.29%537.63M

12.70%5.05B

Financing income

119.29%83.24M

10.98%205.35M

14.48%153.08M

-6.75%89.36M

-28.51%37.96M

39.66%185.03M

48.23%133.72M

62.74%95.83M

156.88%53.1M

56.14%132.48M

Financing cost

-15.36%-188.18M

1.19%-792.86M

5.11%-548.85M

3.72%-354.31M

18.63%-163.12M

-11.13%-802.4M

-20.76%-578.44M

-16.54%-367.99M

-45.01%-200.47M

-77.61%-722.07M

Special items of earning before tax

-66.22%-37.35M

48.69%-57.41M

-63.46%-36.51M

-91.85%-30.94M

-558.17%-22.47M

-343.03%-111.88M

26.32%-22.33M

27.28%-16.13M

70.64%-3.41M

26.77%-25.25M

Earning before tax

149.49%1.25B

20.39%4.95B

64.95%3.45B

50.74%2.02B

42.03%500.16M

-4.95%4.11B

-27.38%2.09B

-22.72%1.34B

-3.00%352.15M

8.48%4.33B

After-tax profit from continuing operations

145.47%846.63M

19.79%3.54B

58.53%2.51B

37.02%1.4B

18.12%344.91M

-8.22%2.95B

-28.93%1.58B

-24.32%1.02B

3.28%291.98M

6.43%3.22B

Earning after tax

145.47%846.63M

19.79%3.54B

58.53%2.51B

37.02%1.4B

18.12%344.91M

-8.22%2.95B

-28.93%1.58B

-24.32%1.02B

3.28%291.98M

6.43%3.22B

Minority profit

95.06%216.51M

27.46%684.69M

13.47%501.28M

1.83%296.45M

-3.07%111M

17.81%537.19M

26.49%441.78M

84.98%291.13M

229.61%114.52M

40.44%455.98M

Profit attributable to shareholders

169.39%630.12M

18.09%2.85B

76.01%2B

51.05%1.1B

31.80%233.91M

-12.52%2.42B

-39.26%1.14B

-38.74%730.55M

-28.43%177.47M

2.34%2.76B

Basic earnings per share

172.73%0.3

18.10%1.37

76.36%0.97

51.43%0.53

22.22%0.11

-12.78%1.16

-38.89%0.55

-39.66%0.35

-25.00%0.09

2.31%1.33

Diluted earnings per share

163.64%0.29

16.81%1.32

67.27%0.92

48.57%0.52

37.50%0.11

-14.39%1.13

-38.89%0.55

-38.60%0.35

-33.33%0.08

3.13%1.32

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified Opinion

Auditor

Ernst & Young Huaming Certified Public Accountants (Special General Partnership)

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q9)Sep 30, 2025	(Q6)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023
Turnover	24.40%8.91B	3.31%35.35B	1.27%25.03B	-1.17%16.05B	1.10%7.16B	1.36%34.22B	2.29%24.72B	2.56%16.24B	6.87%7.08B	10.79%33.76B
Operating income	24.40%8.91B	3.31%35.35B	1.27%25.03B	-1.17%16.05B	1.10%7.16B	1.36%34.22B	2.29%24.72B	2.56%16.24B	6.87%7.08B	10.79%33.76B
Operating expenses	-16.43%-6.16B	4.28%-24.67B	6.03%-17.65B	8.00%-11.41B	4.37%-5.29B	-4.16%-25.77B	-5.46%-18.78B	-3.56%-12.4B	-4.65%-5.53B	-10.05%-24.74B
Gross profit	46.96%2.75B	26.46%10.68B	24.35%7.38B	20.84%4.64B	20.62%1.87B	-6.31%8.45B	-6.59%5.94B	-0.51%3.84B	15.61%1.55B	12.86%9.02B
Selling expenses	-17.90%-447.49M	-14.37%-1.72B	0.68%-1.19B	3.21%-762.59M	4.29%-379.55M	1.26%-1.5B	-7.82%-1.2B	-13.90%-787.87M	-6.49%-396.56M	-10.72%-1.52B
Administrative expenses	-24.97%-573.41M	-18.28%-2.22B	-9.45%-1.49B	-3.50%-939.87M	0.24%-458.85M	-3.34%-1.88B	-5.16%-1.36B	-13.23%-908.11M	-15.87%-459.96M	-14.96%-1.82B
Research and development expenses	4.41%-30.42M	-3.13%-246.22M	7.90%-107.68M	-1.79%-72.22M	6.37%-31.82M	20.71%-238.74M	29.66%-116.92M	-21.62%-70.95M	-191.83%-33.98M	-285.22%-301.1M
Profit from asset sales	8,584.61%22.63M	-88.69%84.84M	-21.97%15.6M	-107.35%-453.06K	-139.26%-266.72K	75.80%749.84M	186.88%19.99M	16.07%6.16M	207.70%679.43K	6,055.61%426.53M
Revaluation surplus	74.34%-3.44M	-125.22%-2.79M	-118.60%-2.38M	-65.82%2.13M	-1,689.91%-13.4M	130.31%11.05M	134.61%12.82M	116.17%6.23M	102.10%842.79K	-291.91%-36.44M
-Changes in the fair value of other assets	74.34%-3.44M	-125.22%-2.79M	-118.60%-2.38M	-65.82%2.13M	-1,689.91%-13.4M	130.31%11.05M	134.61%12.82M	116.17%6.23M	102.10%842.79K	-291.91%-36.44M
Impairment and provision	-49.78%555.96K	36.82%-108.65M	3.35%-38.03M	21.13%-30.29M	-50.90%1.11M	16.46%-171.98M	25.34%-39.35M	35.28%-38.4M	123.12%2.26M	-52.05%-205.87M
-Other impairment is provision	-49.78%555.96K	36.82%-108.65M	3.35%-38.03M	21.13%-30.29M	-50.90%1.11M	16.46%-171.98M	25.34%-39.35M	35.28%-38.4M	123.12%2.26M	-52.05%-205.87M
Special items of operating profit	-15.26%25.62M	-28.04%217.68M	-7.92%135.34M	-16.96%72.29M	-20.91%30.24M	29.08%302.52M	-17.79%146.99M	-23.02%87.06M	-45.65%38.23M	-0.04%234.36M
Operating profit	86.08%1.55B	18.96%5.84B	43.51%4.05B	41.70%2.49B	54.76%832.06M	-2.77%4.91B	-16.35%2.82B	-12.28%1.76B	21.29%537.63M	12.70%5.05B
Financing income	119.29%83.24M	10.98%205.35M	14.48%153.08M	-6.75%89.36M	-28.51%37.96M	39.66%185.03M	48.23%133.72M	62.74%95.83M	156.88%53.1M	56.14%132.48M
Financing cost	-15.36%-188.18M	1.19%-792.86M	5.11%-548.85M	3.72%-354.31M	18.63%-163.12M	-11.13%-802.4M	-20.76%-578.44M	-16.54%-367.99M	-45.01%-200.47M	-77.61%-722.07M
Special items of earning before tax	-66.22%-37.35M	48.69%-57.41M	-63.46%-36.51M	-91.85%-30.94M	-558.17%-22.47M	-343.03%-111.88M	26.32%-22.33M	27.28%-16.13M	70.64%-3.41M	26.77%-25.25M
Earning before tax	149.49%1.25B	20.39%4.95B	64.95%3.45B	50.74%2.02B	42.03%500.16M	-4.95%4.11B	-27.38%2.09B	-22.72%1.34B	-3.00%352.15M	8.48%4.33B
After-tax profit from continuing operations	145.47%846.63M	19.79%3.54B	58.53%2.51B	37.02%1.4B	18.12%344.91M	-8.22%2.95B	-28.93%1.58B	-24.32%1.02B	3.28%291.98M	6.43%3.22B
Earning after tax	145.47%846.63M	19.79%3.54B	58.53%2.51B	37.02%1.4B	18.12%344.91M	-8.22%2.95B	-28.93%1.58B	-24.32%1.02B	3.28%291.98M	6.43%3.22B
Minority profit	95.06%216.51M	27.46%684.69M	13.47%501.28M	1.83%296.45M	-3.07%111M	17.81%537.19M	26.49%441.78M	84.98%291.13M	229.61%114.52M	40.44%455.98M
Profit attributable to shareholders	169.39%630.12M	18.09%2.85B	76.01%2B	51.05%1.1B	31.80%233.91M	-12.52%2.42B	-39.26%1.14B	-38.74%730.55M	-28.43%177.47M	2.34%2.76B
Basic earnings per share	172.73%0.3	18.10%1.37	76.36%0.97	51.43%0.53	22.22%0.11	-12.78%1.16	-38.89%0.55	-39.66%0.35	-25.00%0.09	2.31%1.33
Diluted earnings per share	163.64%0.29	16.81%1.32	67.27%0.92	48.57%0.52	37.50%0.11	-14.39%1.13	-38.89%0.55	-38.60%0.35	-33.33%0.08	3.13%1.32
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	Unqualified Opinion	--	--	--	Unqualified Opinion	--	--	--	Unqualified Opinion
Auditor	--	Ernst & Young Huaming Certified Public Accountants (Special General Partnership)	--	--	--	Ernst & Young Huaming Certified Public Accountants (Special General Partnership)	--	--	--	Ernst & Young Huaming Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"